ARiSe: Anchor for Robotic Sacrocolpopexy

Sponsor
Kaiser Permanente (Other)
Overall Status
Unknown status
CT.gov ID
NCT03378622
Collaborator
University of California, San Diego (Other)
53
1
2
25.1
2.1

Study Details

Study Description

Brief Summary

  1. PRIMARY OBJECTIVE: To assess the effect of absorbable anchor compared to suturing for mesh attachment to vagina in robotic assisted sacrocolpopexy on the length of surgery for this portion of the procedure.

  2. SECONDARY OBJECTIVES:

  1. To assess intraoperative and ii. postoperative complication rates, iii. Intraoperative 10 cm visual analog scale (VAS), to subjectively assess surgeon satisfaction with the technique iv. post-operative Pelvic Organ Prolapse Quantification (POPQ) evaluation for anatomic failure and v. a VAS of the vaginal walls overall appearance
Condition or Disease Intervention/Treatment Phase
  • Other: Anchor
  • Other: Suture
Phase 3

Detailed Description

By applying a commonly used surgical technique of absorbable anchors to a new surgery, Sacrocolpopexy (SCP), operative time may be decreased while providing similar patient outcomes. Absorbable anchors have been validated in mesh fixation during laparoscopic surgical repair of hernias. This technique potentially takes less time than traditional suturing, thus decreasing cost and morbidity of anesthesia. The investigators hypothesis proposes that for women undergoing SCP at a large managed care organization, participants receiving anchor suture staples to attach the mesh to the vagina compared to participants receiving standard treatment will require 50% shorter surgical time for the mesh attachment portion of the surgery. The investigators secondary hypothesis is for women undergoing SCP at a large managed care organization, participants receiving anchor suture staples to attach the mesh to the vagina compared to participants receiving standard treatment will have similar rates of intra-operative and post-operative complications and surgical failure. On VAS, patients will not have different appearance of the vaginal walls. Surgeons will report higher satisfaction with the anchor technique.

Study Design

Study Type:
Interventional
Actual Enrollment :
53 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Use of Anchor Versus Suturing for Attachment of Vaginal Mesh in Minimally Invasive Sacrocolpopexy
Actual Study Start Date :
Nov 29, 2017
Anticipated Primary Completion Date :
Jan 1, 2020
Anticipated Study Completion Date :
Jan 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Anchor

Anchor used for mesh attachment

Other: Anchor
Anchor technique for mesh attachment

Active Comparator: Suture

Suture used for mesh attachment

Other: Suture
Suture technique for mesh attachment

Outcome Measures

Primary Outcome Measures

  1. Mesh Attachment Time [Assessed at one time point, during the participants surgery.]

    Mesh Attachment Time

Secondary Outcome Measures

  1. Perioperative Complications [Assessed at one time point, during the participants surgery.]

    Perioperative Complications

  2. Postoperative Complications [Assessed at two time points, 6 weeks and 6 months postoperatively]

    Postoperative Complications

  3. Surgeon Satisfaction [Assessed at one time point, during the participants surgery.]

    Surgeon Satisfaction assessed using a visual analog scale (10 point)assessment of satisfaction

  4. Surgical Failure [Assessed at two time points, 6 weeks and 6 months postoperatively]

    Surgical Failure assessed using the pelvic organ prolapse quantification scoring system.

  5. Vaginal wall appearance [Assessed at two time points, 6 weeks and 6 months postoperatively]

    Vaginal wall appearance assessed using a using a visual analog scale (10 point)assessment of overall appearance as well as sub-categories of anterior and posterior walls.

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age 21 or older

  • Diagnosis of POP, defined as the descent of one or more of four different anatomic structures, a)the uterus(cervix), b)the apex of the vagina (in those status post hysterectomy) c) the anterior vaginal wall, or d) the posterior vaginal wall. This is defined on exam as the POPQ points Ba, C, or Bp >0 cm beyond the hymen, uterine(cervix) descent into at least the lower half the vagina (defined as point c> -tvl/2) or post hysterectomy vault into the lower 2/3 of the vagina. Bothersome bulge symptoms as indicated on question 3 of the Pelvic Floor Disorder Inventory (PFDI-20) form relating to 'sensation of bulging' or something 'falling out'

  • Desire surgical treatment for POP with SCP

  • Available for up to 6 months of follow up

  • Not pregnant or desiring future pregnancy

  • Written informed consent is obtained.

Exclusion Criteria:
  • Known adverse reaction to synthetic mesh, or complications including but not limited to erosion, fistula, or abscess.

  • Cervical intraepithelial neoplasia (cervical intraepithelial neoplasia (CIN) 2, CIN3, or cancer)

  • Unresolved chronic pelvic pain

  • Prior abdominal or pelvic radiation

  • Contraindications to the surgical procedures including known horseshoe kidney, pelvic abscess or active diverticular abscess or diverticulitis

Contacts and Locations

Locations

Site City State Country Postal Code
1 Kaiser Permanent San Diego San Diego California United States 92110

Sponsors and Collaborators

  • Kaiser Permanente
  • University of California, San Diego

Investigators

  • Study Director: Alexander A Berger, Kaiser Permanente
  • Principal Investigator: Shawn A Menefee, MD, Kaiser Permanente

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Kaiser Permanente
ClinicalTrials.gov Identifier:
NCT03378622
Other Study ID Numbers:
  • 11460
First Posted:
Dec 20, 2017
Last Update Posted:
Mar 6, 2019
Last Verified:
Mar 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 6, 2019